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A B S T R A C T
Objective: A multisite field trial testing whether improved outcomes associated with intensive referral to
mutual help groups (MHGs) could be maintained after the intervention was adapted for the
circumstances and needs of rural veterans in treatment for substance use disorder (SUD).
Methods: In three Veterans Affairs treatment programs in the Midwest, patients (N = 195) received
standard referral (SR) or rural-adapted intensive referral (RAIR) and were measured at baseline and 6-
month follow-up.
Results: Both groups reported significant improvement at 6-months, but no significant differences
between SR and RAIR groups in MHG participation, substance use, addiction severity, and posttraumatic
stress symptoms. Inconsistent delivery of the intervention resulted in only one-third of the RAIR group
receiving the full three sessions, but this group reported significantly greater 6-month abstinence from
alcohol than those receiving no sessions.
Conclusion: Further research should explore implementation problems and determine whether
consistent delivery of the intervention enhances 12-step facilitation.
Practice implications: The addition of rural-specific elements to the original intensive referral intervention
has not been shown to increase its effectiveness among rural veterans.
© 2017 Elsevier B.V. All rights reserved.
1. Introduction
Nearly all service members deployed to Iraq and Afghanistan
report facing hostile incoming fire (97%), but most also face
additional traumas and stressors, including seeing people begging
for food (97%), concern about enemy attack (77%), and concern
about family and friends on the homefront (54%)[1]. An estimated
40% report substantial reintegration problems, including difficulty
confiding personal thoughts (56%) and controlling anger (57%) [2].
An estimated 41% may have had post-traumatic stress disorder
(PTSD) and 38% an alcohol use problem [2]. Approximately one-
third of community samples seeking SUD treatment have co-
morbid post-traumatic stress disorder (PTSD) [3] and the
prevalence among veterans is likely higher [4].
Treatment for substance use disorders requires time. Patients
show better outcomes with contact over a 12-month period,
including 3 to 6 months of continuing care [5]. Post-treatment
continuing care involves lower-intensity engagement in an
outpatient setting [5], and it is helps prevent relapse after
intensive SUD treatment [6]. Social support is a primary
component of continuing care, and a protective factor for SUD
treatment relapse [7] and post-deployment traumatic stress
symptoms [8].
A mutual-help group (MHG) is any group of individuals who
meet regularly to share experiences managing a common problem.
Social support provided by MHGs like Alcoholics Anonymous and
other 12-step groups improves outcomes [6,9], even for those with
concurrent PTSD and SUD [10], and efforts to promote participa-
tion reduce continuing care costs [7]. Post-treatment referral to
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mutual-help groups has been described as “an effective, low-cost
option” [8] but treatment providers vary in consistency and
methods of referral [11].
Rural veterans have disproportionately served in Operation
Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) [12]
and are returning to their communities with significant substance
use disorder (SUD) and trauma-related symptoms [13,14]. Howev-
er, rural veterans have less access than non-rural veterans to
continuing care in an outpatient setting [15,16]. Additionally, rural
veterans attending MHG meetings are likely to have challenges
unique to their rural settings. In rural communities veterans are
more likely to be recognized by others [17,18] and rural residents
rate MHGs as less acceptable than urban residents do [19]. Further,
the only mutual-help groups consistently available in many small
or rural communities are AA meetings which may cause some
ambivalence in those with problems other than alcohol [20]. In
short, MHG referral does not occur in a standardized way and rural
residents facing barriers to accessing continuing care may also face
barriers to engaging with MHGs.
The purpose of this study is to determine whether a structured,
intensive referral to mutual-help groups can be adapted to the
circumstances of rural veterans while maintaining effectiveness. In
a study of urban veterans leaving treatment, Timko and
DeBenedetti [21] found 1-year SUD abstinence rates improved
more than 24% with a three-step intensive referral intervention
which (1) educated patients on the benefits of mutual-help groups,
(2) identified an upcoming local meeting and recovery buddy to
accompany the patient, and (3) followed up on attendance [22]. For
those with a dual-diagnosis of SUD and PTSD, this intensive referral
intervention was associated with an 18% reduction in the number
of psychiatric symptoms and a 26% reduction in perceived need for
mental health treatment [23].
During typical intensive residential SUD treatment, veterans
attend nearby mutual-help meetings, develop sober relationships,
and obtain a sponsor, who serves as a mentor providing advice and
assistance. Urban and suburban patients often live near their
treatment center and can maintain those relationships upon
transitioning to the home environment, but rural patients typically
do not live within commuting distance. Upon discharge, rural
veterans return to communities without these supports, and are at
higher risk of relapse [24,25]. Family members are another source
of social support preventing SUD relapse [26,27]. Family members
are encouraged to support treatment by attending regular sessions
which prepare them for the relational turbulence which accom-
panies recovery. Family members of rural veterans are less likely to
attend family sessions and typically have no support themselves
[28], thus rural veterans may not receive the same family support
benefits that urban veterans do [28].
The current study tests a rural-adapted intensive referral (RAIR)
which modifies the original intensive referral intervention by
identifying an MHG meeting and recovery buddy in the home
community and educating family members on the importance of
MHG participation. We tested the following hypotheses in a
multisite field trial: Compared to the control condition of standard
referral, RAIR will be associated with more MHG affiliation, less use
of alcohol and other drugs, and reduced PTSD symptomology. To
our knowledge, this is the first evidence-based substance use
intervention modified for rural veterans.
The RAIR intervention consisted of three sessions and resources
including a flowchart for each session, handouts, a self-help
journal, and a list with meeting locations and mutual-help buddies
in towns throughout the region. (Materials are available from the
corresponding author.) This list of meetings and buddies covered
each recruitment site as well as rural communities of central and
eastern Nebraska. The sessions provided a trajectory for fully
integrating clients into a recovery network, but staff were given
flexibility to adapt to each client’s familiarity with MHGs and need
for support.
The initial face-to-face session took place either in individual or
in group sessions. Staff assessed participants’ knowledge and
experience of MHGs, explained the importance of meeting
attendance (handout 1), scheduled a MHG meeting to attend
before the next session, arranged for the client to meet a MHG
buddy at that meeting, provided a journal to record experiences,
and sought permission to contact a family member (family
handout mailed to the family member).
The subsequent two sessions followed-up on MHG attendance
and participation and could be completed in person or by phone.
The second session addressed whether and why MHG attendance
and buddy contacts were successful. Expectations for MHG
meeting behaviors were discussed (handout 2), and if buddy or
family support was still needed, contact efforts were undertaken.
The third session was similar, but the focus shifted to trouble-
shooting participation barriers (handout 3) and planning for
sponsorship, service, and other forms of MHG participation
(handout 4). The original intensive referral intervention [21]
Table 1
Baseline Characteristics of Standard and Intensive Referral Patients.
Total
(N = 195)
Standard
(n = 89)
RAIR
(n = 106)
X2/t p
Male, N (%) 178 (91.3%) 83 (93.3%) 95 (89.6%) .80 .37
Caucasian, N (%) 150 (76.9%) 69 (77.5%) 81 (76.4%) .03 .85
Hispanic, N (%) 11 (5.6%) 7 (7.9%) 4 (3.8%) 1.52 .22
Married, N (%) 53 (27.2%) 26 (29.2%) 27 (25.5%) .34 .56
Rural City or Town, N (%) 61 (31.3%) 22 (24.7%) 39 (36.8%) 3.28 .07
Age, M (SD) 46.86 (12.25) 46.37 (12.64) 47.26 (11.96) .51 .61
AAAS Score, M (SD) 4.69 (1.96) 4.64 (2.08) 4.74 (1.87) .33 .74
Attended MHG ever, N (%) 193 (99.0%) 88 (98.9%) 105 (99.1%) .02 .90
Attended MHG past year, N (%) 190 (97.9%) 85 (96.6%) 105 (99.1%) 1.45 .23
# Meetings in past year, M (SD) 45.56 (74.46) 42.75 (65.19) 47.89 (81.60) .48 .63
PTSD Checklist, M (SD) 46.66 (18.02) 45.05 (18.18) 48.01 (17.87) 1.15 .25
ASI-L alcohol, M (SD) .39 (.27) .43 (.27) .37 (.27) 1.51 .13
ASI-L drug use, M (SD) .09 (.11) .07 (.10) .10 (.12) 1.87 .06
30-day substance use
Alcohol, N (%) 137 (70.3%) 66 (74.2%) 71 (67.0%) 1.19 .28
Cannabis, N (%) 47 (24.1%) 15 (16.9%) 32 (30.2%) 4.70 .03
Methamphetamine, N (%) 27 (13.8%) 10 (11.2%) 17 (16.0%) .94 .33
Cocaine or crack, N (%) 24 (12.3%) 8 (9.0%) 16 (15.1%) 1.67 .20
Note: RAIR = rural-adapted intensive referral; MHG = mutual-help group. M = mean; SD = standard deviation.
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relied on the same MHG buddies to provide support to the patient
during and after treatment, whereas rural RAIR participants might
have one buddy during treatment and a different one on returning
to their home community.
2. Materials and methods
2.1. Research design
This field trial used a pretest-posttest quasi-experimental
design. Patients entering treatment were assigned to an addiction
therapist (AT), half of whom had been trained in RAIR. Those not
trained in RAIR provided their standard referral (SR), typically a
recommendation to find and attend MHG meetings upon
completing residential/intensive outpatient treatment, although
referral practices vary [11]. Patents were pretested at baseline and
followed-up six months later on measures of mutual-help group
affiliation, substance use, and PTSD.
2.2. Sampling
The Institutional Review Board of the Department of Veterans
Affairs (VA) Nebraska-Western Iowa Health Care System (VA
NWIHCS) approved and monitored human subjects’ participation.
Participants were enrolled from three VA intensive SUD treatment
sites in Nebraska that serve rural and urban veterans. Zip code of
residence prior to treatment entry determined rural/urban status
utilizing Rural-Urban Commuting Area codes [29].
Eligibility criteria included being at least 19 years of age and
having no evidence of cognitive impairment on the Mini-Cog [30].
Those who provided informed consent were enrolled. In-person
baseline interviews collected data on demographic characteristics,
addiction severity, social support, traumatic events and sympto-
mology, and mutual-help group participation. Six-month follow-
up interviews were done in-person or by telephone. Data
collection began March, 1, 2013, and concluded December 11, 2014.
A total of 195 participants enrolled and provided baseline data
for analysis. Their characteristics are provided in Table 1. Reflective
of the region’s veteran population, the baseline sample overall was
middle-aged and mostly male, white, non-Hispanic, and unmar-
ried. Sixty-one (31.3%) provided residential zip codes qualifying as
rural city or town, with no significant difference between SR and
RAIR groups. The Alcoholics Anonymous Affiliation Scale (AAAS)
revealed widespread exposure to MHGs at baseline. The mean
PTSD Checklist (PCL) score of 46.66 (SD = 18.02) was just below the
VA’s recommended threshold of 50.00 for a PTSD diagnosis.
Very low drug severity subscores on the Addiction Severity
Index-Lite (ASI-L; Table 1) suggest baseline alcohol use was more
problematic than drug use. More than two-thirds of participants
had consumed alcohol within 30 days of baseline and nearly one
quarter had consumed cannabis. Use of methamphetamine and
cocaine/crack was reported by a minority of participants, but other
substances (e.g. opiates, stimulants, etc.) were either not reported
or used by less than 10% of participants at baseline and therefore
not analyzed. Those assigned to the RAIR condition did not differ
significantly from those receiving SR, with the exception that a
greater percentage of those assigned to RAIR than to SR had
consumed cannabis (30% vs. 17%, p = .03).
2.3. Instruments used
The independent variable was type of assignment at baseline:
standard referral (SR) or rural-adapted intensive referral (RAIR).
Patients in RAIR, however, did not consistently receive the full
intervention, so additional exploratory analysis compared those
who received no RAIR sessions with those who received the full 3
sessions of RAIR. Additional analysis tested for a dose effect among
those receiving no sessions, 1–2 sessions, and 3 sessions.
The dependent variable of MHG affiliation was determined by
responses to the Alcoholics Anonymous Affiliation Scale (AAAS)
[31], modified to include a range of 12-step MHGs. Total scores
range from 0 to 9, with higher scores indicating greater affiliation.
The measure shows adequate reliability and validity [31,32]. In this
sample, the measure displayed adequate reliability, as measured
by Cronbach’s alpha, at both baseline (a = 0.71) and follow-up
(a = 0.77).
Substance use was measured several ways. The Timeline
Follow-Back (TLFB) measure [33] documents frequency and
quantity of use of a variety of substances during the previous
30 days. Outcome measures included percent days abstinent and
use per using day for each substance.
The Addiction Severity Index-Lite (ASI-L) [34] also measured
severity of use for alcohol (ASI-L alcohol) and for other drugs (ASI-L
drug use). Scores in each domain range from 0 to 1. The ASI-L
alcohol subscale includes six items and yielded Cronbach’s alpha of
0.88 for the baseline measure. The ASI-L drug use subscale includes
11 items addressing an array of drugs other than alcohol and also
yielded satisfactory baseline reliability (a = 0.78).
The PTSD checklist [35] consists of 17 questions relating to three
PTSD symptoms: intrusive thoughts (5 items), avoidance (7 items),
and hyperarousal (5 items). Possible scores range from 17 to 85,
with higher scores indicating greater symptom severity. Reliability
using Cronbach’s alpha was excellent (a = 0.95).
2.4. Data collection and procedures
Patients received standard referral or RAIR depending on the
addiction therapist (AT), with caseload typically determining who
was assigned each incoming patient. Veterans were approached
for study participation after initial admission assessments were
completed, precluding random assignment and more closely
approximating ‘real world’ procedures of SUD treatment programs.
Eleven ATs (six males and five females) staffed the three
recruitment sites. All ATs were educated about the rationale for
RAIR and were encouraged to notify the Principal Investigator of
their interest in being trained in RAIR. Three males and two
females were trained in RAIR. An equal number of staff at each site
with master’s degrees were trained in RAIR or provided SR.
Scheduling demands and AT specialization precluded randomiza-
tion.
The intervention group received RAIR from their AT, a peer
support specialist (PSS), or physician trained in the intervention.
Initially, the PI (a physician) trained the RAIR ATs in the
intervention using role plays and group sessions with veterans.
It became evident that the RAIR-trained ATs did not consistently
have time to perform RAIR and a study published in late 2012
showed referral to 12-step support groups was significantly more
effective when delivered by peers than by clinicians [36]. Given
this evidence for enhanced effectiveness, we trained PSSs to
perform the intervention.
2.5. Data analysis
Data were entered into SPSS Statistics version 22.0 (IBM Corp.,
Armonk, New York). Data analysis included Pearson’s chi-square
analysis, independent samples t-test, and analysis of covariance
(ANCOVA). Two-tailed tests were used throughout and the
threshold for a type I error was p < 0.05. Two hundred and two
individuals were consented for study participation, but we have
baseline data on only 195 participants and follow-up data on 140.
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3. Results
3.1. Primary outcomes
Of the 195 baseline enrollees, 140 (72%) were successfully
followed-up at six months. Those followed-up were older
(M = 48.39, SD = 12.54) than those not followed-up (M = 42.96,
SD = 10.62, p = .005). Otherwise, ethnicity, marital status, MHG
participation, PTSD symptomology, addiction severity, and 30-day
substance use measured at baseline did not significantly differ
between those who were and were not followed up (results not
shown).
Initial tests were conducted to determine the effectiveness of
SUD treatment overall for the entire sample. As shown in Table 2,
participants significantly improved on most measures of MHG
involvement, substance use, and PTSD. The improvements did not
reach statistical significance in use per using day for alcohol and
cannabis (not reported) and in the percent of participants
abstinent from cannabis. Insufficient sample size of those
reporting drug use prevented statistical comparison of use per
using day for methamphetamine and cocaine in this analysis, and
for cannabis, methamphetamine, and cocaine in subsequent
analyses.
Those assigned to SR and to RAIR were compared across an
array of mutual-help group and substance use outcome variables
(Table 3). For continuous variables, test statistics were calculated
using ANCOVA with the baseline value of the variable entered as a
control and the follow-up value used as the dependent variable.
The remaining ANCOVAs showed no significant differences,
suggesting assignment to the SR or RAIR group was not associated
with substance use or MHG participation. The groups were also
compared on the percent reporting abstinence from alcohol and
from other drugs in the 30 days prior to the follow-up interview.
Chi-square analysis revealed no significant difference between the
groups.
Not all those assigned to receive RAIR actually received all three
prescribed sessions. Of the 106 participants assigned to the RAIR
condition at baseline, only 61 (58%) received the first session and
fewer received the second (N = 38, 36%) and third sessions (N = 27,
26%). Veterans are assigned to levels of SUD treatment utilizing the
American Society of Addiction Medicine Patient Placement
Criteria. The veterans eligible for this study (those in residential
or intensive outpatient treatment) were severely impaired and had
the greatest treatment needs, often having multiple prior SUD
treatments. Their ATs reported that the time required for
addressing the severity of their addiction and its sequelae
prevented them from consistently performing RAIR. We therefore
performed exploratory analyses using as the control group all who
received no RAIR sessions and using as the intervention group
those who received all three sessions, as the intervention was
designed. The “no sessions” control included both those who were
assigned to receive SR, and those assigned to receive RAIR but who
did not receive any sessions. Results (Table 4) indicate only one
statistically significant difference between those receiving no RAIR
sessions and those receiving all three. The percentage of
participants reporting 30-day abstinence from alcohol was
significantly higher in the 3-session group than in the zero-
session group (96% vs. 78%, p = .03).
Table 2
Mutual-help Group Involvement, Substance Use, and PTSD: Before and After
Treatment for Entire Sample.
Dependent Variable Baseline Follow-up Paired t-test
Mean SD Mean SD d.f. t p
AAAS Score 4.64 1.98 5.37 2.15 136 4.32 .00
# Meetings in recent months 42.72 69.59 69.07 66.00 137 3.87 .00
# Other 7 MHG behaviors 3.70 1.70 4.17 1.83 139 3.11 .00
PTSD Checklist 45.87 18.34 36.09 18.65 136 7.00 .00
ASI-L Alcohol .40 .26 .17 .18 134 9.55 .00
ASI-L Drug Use .08 .11 .03 .05 136 6.85 .00
Percent days abstinent
Alcohol 60.91 37.09 92.37 21.46 138 9.76 .00
Cannabis 90.38 25.11 98.59 10.22 138 3.89 .00
Methamphetamine 94.44 19.44 99.90 1.13 138 3.38 .00
Cocaine 96.59 13.86 100.00 N/A 138 2.90 .00
Use per using day
Alcohol (n = 25): # drinks 20.16 23.53 14.67 17.53 24 1.01 .32
Participants abstinent N % N % d.f. X2 p
From alcohol 38 27.1 114 81.4 1 8.76 .00
From other drugs 83 59.3 127 90.7 1 2.58 .11
Note: N = 140; paired-samples t-tests. SD = standard deviation.
Table 3
Follow-up Mutual-help Group Involvement, Substance Use, and PTSD: Intention-to-
Treat.
Dependent Variable Standard
(n = 63)
RAIR
(n = 77)
ANCOVA
Mean SD Mean SD d.f. F p
AAAS Score 5.26 2.21 5.48 2.10 1 .04 .85
# Meetings in 6 months 65.26 72.99 72.12 60.13 1 .08 .78
# Other 7 MHG behaviors 4.11 1.85 4.21 1.82 1 .17 .68
PTSD Checklist 34.87 19.55 37.21 17.85 1 .02 .89
ASI-L Alcohol .16 .17 .17 .19 1 .25 .62
ASI-L Drug Use .02 .04 .03 .06 1 .82 .37
Percent days abstinent
Alcohol 92.43 21.19 92.42 21.69 1 .00 .99
Cannabis 99.95 .42 97.49 13.67 1 1.49 .22
Methamphetamine 100.00 .00 99.83 1.52 1 .38 .54
Cocaine 100.00 .00 100.00 .00 1 N/A N/A
Use per using day
Alcohol (N = 25): # drinks 11.47 5.94 17.63 23.71 1 .51 .49
Participants abstinent N % N % d.f. X2 p
From alcohol 51 81.0 63 81.8 1 .02 .90
From other drugs 60 95.2 67 87.0 1 2.78 .10
Note: The control variable for each ANCOVA is the baseline measure of the
dependent variable. SD = standard deviation.
Table 4
Follow-up Mutual-help Group Involvement, Substance Use, and PTSD: Actually
Treated.
Dependent Variable No Sessions
(n = 91)
3 Sessions
(n = 26)
ANCOVA
Mean SD Mean SD d.f. F p
AAAS Score 5.40 2.14 5.33 2.33 1 .00 .98
# Meetings in 6 months 67.61 69.48 71.12 45.99 1 .02 .90
# Other 7 MHG behaviors 4.20 1.80 4.08 2.10 1 .05 .82
PTSD Checklist 36.20 20.27 33.16 15.13 1 1.74 .19
ASI-L Alcohol .17 .18 .15 .18 1 .04 .84
ASI-L Drug Use .03 .05 .03 .05 1 .06 .80
Percent days abstinent
Alcohol 91.32 21.83 96.15 19.61 1 .70 .41
Cannabis 99.71 1.62 96.15 19.61 1 3.51 .06
Methamphetamine 100.00 .00 99.49 2.61 1 N/A N/A
Cocaine 100.00 .00 100.00 .00 1 N/A N/A
Use per using day
Alcohol (n = 20): # drinks 17.05 19.40 16.0 N/A 1 .00 .99
Participants abstinent N % N % d.f. X2 p
From alcohol 71 78.0 25 96.2 1 4.51 .03
From other drugs 84 92.3 23 88.5 1 .38 .54
Note: The control variable for each ANCOVA is the baseline measure of the
dependent variable. SD = standard deviation.
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3.2. Additional exploratory analyses
RAIR was not designed to be dose-specific, but we tested for a
dose effect by placing participants in three dose categories: no
sessions, partial (1–2 sessions), or full (3 sessions). Results revealed
no significant between-groups differences (results not shown).
Finally, RAIR was designed to increase MHG participation across
a range of attitudes and behaviors, so we compared the no RAIR
and full RAIR groups on individual AAAS items: attending
meetings, identifying as a member, calling members for help,
having a sponsor, being a sponsor, having a spiritual awakening,
reading literature, and providing service. We found no significant
differences on these attitudes and behaviors (results not shown).
4. Discussion and conclusion
This field trial of a rural-adapted intensive referral to mutual
help-groups found no significant difference between the RAIR and
SR groups in any of the dependent variables. Compared to the no-
sessions group, those receiving the full 3-sessions of RAIR showed
no additional improvement on measures including MHG partici-
pation, PTSD symptoms, addiction severity, percent days abstinent,
and alcohol use per using day. A significantly higher proportion of
those who received the intervention as designed, however, were
abstinent from alcohol at follow-up. Potential explanations will be
considered.
First, the high level of baseline MHG participation among this
sample is noteworthy because it leaves less room for improvement.
In their six-month outcomes for the original intensive referral
intervention, Timko, DeBenedetti, and Billow [37] reported six
measures of baseline 12-step affiliation for their sample entering
an urban VA outpatient SUD treatment facility. The sample in the
present (RAIR) study was higher than the 2006 study on five of the
behaviors: being a sponsor (11.3% vs. 7.0%), having a spiritual
awakening (46.9% vs. 44.9%), reading MHG literature (96.4% vs.
81.3%), providing service (60.5% vs. 50.6%), and ever attending a
meeting (99.0% vs. 96.8%). The present (RAIR) study reported lower
rates than the 2006 study of having a sponsor (32.3% vs. 55.4%),
perhaps because finding sponsors in rural areas is more challeng-
ing.
Baseline MHG behaviors reported in the present sample and in
the earlier research on intensive referral indicate the majority of
veterans entering SUD treatment have first-hand experience with
MHGs. The present sample, in particular, may require less of the
basic MHG education that RAIR provides and more of the direct
assistance coordinating support. The three study sites were
employing Twelve Step Facilitation (TSF) as one of their
evidence-based treatment modalities, perhaps making it difficult
to improve upon this threshold of 3–4 MHGs per month reported
by the participants at baseline.
Second, as in the present RAIR study, the original intensive
referral study [37] also found no difference between SR and
intervention groups on MHG meeting attendance, reading litera-
ture, or being a sponsor. Unlike RAIR, that earlier study resulted in
higher rates of having a sponsor, having a spiritual awakening, and
providing service when compared to SR. Yet, when compared to
the SR group in the present RAIR study, that 2006 research on
intensive referral at six month follow-up had lower rates on five
measures of MHG participation common to both studies: having a
sponsor, previously being a sponsor, having a spiritual awakening,
reading literature, and providing service. Meeting attendance
measures were not directly comparable, but did not appear to
diverge substantially. The Timko et al. [37] study achieved greater
reductions in ASI drug use than did the present study’s SR, but a
smaller reduction in ASI alcohol. These comparisons suggest RAIR’s
comparison group achieved results at least comparable to the
original intensive referral. Rather than suggesting intensive
referral is ineffective, the results suggest that standard referral
in the Nebraska VA treatment centers is as effective as intensive
referral, both in its original form and in the rural-adapted intensive
referral. Another possible explanation is that referral to MHGs is
more common today than it was a decade ago.
Third, the preliminary finding that a significantly higher
percentage of 3-session RAIR participants were abstinent from
alcohol in comparison to those who received no RAIR sessions (96%
vs. 81%) suggests the intervention has some effect, even if the
mechanism is unclear. Neither the AAAS scores nor any individual
AAAS behavior significantly differed between the groups, yet a
significantly higher percentage of alcohol-abstinent participants
was documented in the 3-session RAIR group. Similar findings
were reported in an effectiveness study of Making AA Easier
(MAAEZ), a six-week, manual-guided intervention with goals
similar to RAIR. In studying the mediating role of various 12-Step
behaviors and attitudes, Subbaraman, Kaskutas, and Zemore [38]
found that only MHG service work mediated MAAEZ’s effect on
abstinence in the overall sample. If a greater proportion of people
remain abstinent even when they are not engaging more
frequently than others in MHG behaviors, then the mechanism
motivating abstinence is either a MHG behavior or attitude which
has not been measured or, more likely, some aspect of the referral
program is motivating abstinence. Future research should consider
whether the active ingredient is, for instance, reinforcing absti-
nence as a goal [39] or expanding the sober social network via the
group format [40].
Finally, this was the first multisite field trial of intensive referral
and although the staff were trained and routinely monitored for
fidelity, they did not consistently deliver the sessions. A full
implementation study is forthcoming, but a primary implementa-
tion barrier cited by the staff was the amount of time required to
deliver the intervention, particularly the first session, delivered to
only 58% of assigned participants. The limited time patients spend
with an addiction therapist frequently focuses on solving problems
which may not directly relate to post-treatment social support.
Future research should consider the effectiveness of intensive
referral in varied contexts. For instance, is intensive referral more
effective in treatment centers relying on cognitive behavioral
therapy rather than on TSF? The components of the intervention,
and especially the adaptations we integrated, should be examined
for efficacy vis-à-vis the time required to deliver them and the
alternative SR procedures.
Limitations of the study include inconsistent implementation
and enrollment in an exclusively veteran population potentially
limiting generalizability. Those who received RAIR may have been
influenced by the individual delivering it, by mode of delivery, or
by some other variable not measured. A significantly higher
proportion of cannabis users was assigned to receive RAIR, which
may have affected the results, given that Alcoholics Anonymous
and most other MHGs accessible to rural and urban veterans alike
do not focus on problems with marijuana.
5. Conclusion
At six-month follow-up, rural-adapted intensive referral and
standard referral groups did not differ on measures of substance
use, mutual-help group attendance or participation, or post-
traumatic stress symptoms. Additional analyses comparing those
receiving no RAIR sessions to the minority who received the
intervention as designed likewise found no differences, with one
exception: those receiving three sessions were significantly more
likely to be abstinent from alcohol than those receiving no
sessions. If the intervention is to realize its potential, implemen-
tation barriers must be addressed.
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Practice implications
In programs using Twelve Step Facilitation, addiction profes-
sionals’ routine practices to connect rural veterans with MHG
members and meetings are effective. RAIR did not have additional
benefits, possibly because of implementation challenges.
Informed consent and patient details: I confirm all patient/
personal identifiers have been removed or disguised so the patient/
person(s) described are not identifiable and cannot be identified
through the details of the story.
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